Zobrazeno 1 - 10
of 471
pro vyhledávání: '"Serotype replacement"'
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-14 (2024)
Abstract Background Streptococcus pneumoniae is a major cause of mortality globally. The introduction of pneumococcal conjugate vaccines (PCVs) has reduced the incidence of the targeted serotypes significantly, but expansion of non-targeted serotypes
Externí odkaz:
https://doaj.org/article/d53e7a721b12438496c7014fea3bcdc2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pieter T. de Boer, Cornelis H. van Werkhoven, Albert Jan van Hoek, Mirjam J. Knol, Elisabeth A. M. Sanders, Jacco Wallinga, Hester E. de Melker, Anneke Steens
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background New 15- and 20-valent pneumococcal vaccines (PCV15, PCV20) are available for both children and adults, while PCV21 for adults is in development. However, their cost-effectiveness for older adults, taking into account indirect prot
Externí odkaz:
https://doaj.org/article/75ba85013d3d443bbcabcd53b1d3ff7d
Autor:
Andrew Anglemyer, Xiaoyun Ren, Charlotte Gilkison, Zoe Kumbaroff, Julie Morgan, Kara DuBray, Audrey Tiong, Arthur Reingold, Tony Walls
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 46, Iss , Pp 101082- (2024)
Summary: Background: In Aotearoa New Zealand (NZ) PCV7 was introduced in 2008, then PCV10 in 2011 and PCV13 in 2014. In 2017 PCV10 was re-introduced, replacing PCV13. In the present study, we investigate the resultant rapidly changing invasive pneumo
Externí odkaz:
https://doaj.org/article/e4cdff7492af429d82f7fc45a0c7063a
Publikováno v:
F1000Research, Vol 12 (2023)
Pneumococcal disease is a global public health concern as it affects the young, aged and the immunocompromised. The development of pneumococcal vaccines and their incorporation in the immunization programs has helped to reduce the global burden of di
Externí odkaz:
https://doaj.org/article/a4c86c285bc3433dbfdf55626d04a519
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 12, Pp 5628-5637 (2021)
The universal administration of pneumococcal conjugate vaccines (PCVs) had been demonstrated as an effective way to prevent Streptococcus pneumoniae infection. However, the immunity induced by PCVs protected against the infections caused by vaccine s
Externí odkaz:
https://doaj.org/article/b17a8ab4a3234259b5d6696637a2a9a0
Autor:
Paula O. Narváez, Salome Gomez-Duque, Juan E. Alarcon, Paula C. Ramirez-Valbuena, Cristian C. Serrano-Mayorga, Julian Lozada-Arcinegas, Alirio Bastidas, Sandra Gómez, Hernan Vargas, Charles Feldman, Luis Felipe Reyes
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background The incidence of invasive pneumococcal disease (IPD) varies depending on a number of factors, including vaccine uptake, in both children and adults, the geographic location, and local serotype prevalence. There are limited data ab
Externí odkaz:
https://doaj.org/article/7ab608cc1f27477c8c581e3e24cad912
Publikováno v:
BMC Pediatrics, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background Hemophagocytic lymphohistiocytosis (HLH) is an infrequent but life-threatening disease due to excessive immune activation. Secondary HLH can be triggered by infections, autoimmune diseases, and malignant diseases. Streptococcus pn
Externí odkaz:
https://doaj.org/article/a8a5694299af4e41860136b37a068879
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.